Amaranthus caudatus (ACA) (Biotin)

Cat# A1372-22M3-2mg

Size : 2mg

Marca : US Biological

Richiedere ulteriori informazioni

Contatta il distributore locale :


Telefono : +1 850 650 7790


A1372-22M3 Amaranthus caudatus (ACA) (Biotin)

Clone Type
Polyclonal
Grade
Purified
Shipping Temp
Blue Ice
Storage Temp
-20°C

Lectins are derived from the extracts of plants, animals, viruses and microorganisms and are known to agglutinate red blood cells. These agglutinins can select cell types according to blood group activities utilizing sugar-binding mechanisms. ||Lectins form precipitates with glycoconjugates and are useful for identifying or separating oligosaccharides with identical sugar compositions such as galactose, mannose or glucose.||Pure Amaranthus caudatus lectin (ACA) from Tassel flower, Inca wheat, Biotin conjugated.||Carbohydrate Specificity: Galactose beta (1,3) N-Acetylgalactosamine (the T antigen).||Inhibitory Carbohydrate: Lactose>high concentrations of beta-Galactose.||Activity: Less than 0.5ug/ml will agglutinate neuraminidase treated human red blood cells.||Chemical Used for Conjugation: Biotinyl N-hydroxysuccinimide ester (BNOHSE).||Storage and Stability: |May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 6 months after receipt at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

Applications
Purity: Purified|Concentration: ~1mg/ml|Form: Supplied as a liquid in 0.01M PBS, pH 7.2-7.4. Labeled with Biotin.||Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Form
Supplied as a liquid in 0.01M PBS, pH 7.2-7.4. Labeled with Biotin.
Purity
Purified
References
1. Rinderle, S.J., et al. (1989) Abstract from The American Gastroenterology Assoc., American Assoc. for the Study of Liver Diseases. May 14-17, 1989. Washington D.C.